TAVAFLOX
DCI : LEVOFLOXACIN
Dosage 500 mg
Pharmaceutical form Divisible coated tablet
Therapeutic class Infectiology
B/5
Indications
They are limited in the adult treatment of bacterial infections caused by bacteria susceptible to levofloxacin such as: - Acute sinusitis second line - Acute exacerbation of chronic bronchitis - Community-acquired pneumonia bacteremic or not a second-line in adults without risk factors Special situations: Healing anthrax treatment
Download the leaflet